semaglutide compounded claims withdrawn FDA is moving to restrict mass-marketed GLP-1 products that aren' Semaglutide for Weight Loss |

Roughly three-quarters of each group 77% of compounded users and 74% of brand-name users report that the medicine is either effective or extremely effective. One-Third of Compounded GLP-1 Users Have Switched From Brand Name While reported effectiveness is similar between brand-name and compounded or custom-mixed users, the latter variety appears to be gaining momentum in the marketplace

Shen S., Liu B., Fanti C., et al., GlucagonLike Peptide1 (GLP1) Agonist Use and Weight Change Among Patients With Breast Cancer, Journal of Clinical Oncology 42 (2024): 10607

Oct 2021

NICE guidance (NG49) recommends fibrosis risk stratification using FIB-4 scores and Enhanced Liver Fibrosis (ELF) testing for NAFLD patients

Not Covered for Weight Loss TRICARE For Life (as of August 31, 2025) Individuals with direct care only access DoD civilians not enrolled in covered plans The August 2025 change eliminated weight loss medication coverage for TRICARE For Life beneficiaries

Cell Mol Biol (Noisy-le-grand)